Abstract
At the blood-brain barrier (BBB), laminin-α5 is predominantly synthesized by endothelial cells and mural cells. Endothelial laminin-α5 is dispensable for BBB maintenance under homeostatic conditions but inhibits inflammatory cell extravasation in pathological conditions. Whether mural cell-derived laminin-α5 is involved in vascular integrity regulation, however, remains unknown. To answer this question, we generated transgenic mice with laminin-α5 deficiency in mural cells (α5-PKO). Under homeostatic conditions, no defects in BBB integrity and cerebral blood flow (CBF) were observed in α5-PKO mice, suggesting that mural cell-derived laminin-α5 is dispensable for BBB maintenance and CBF regulation under homeostatic conditions. After ischemia-reperfusion (MCAO) injury, however, α5-PKO mice displayed less severe neuronal injury, including reduced infarct volume, decreased neuronal death, and improved neurological function. In addition, α5-PKO mice also showed attenuated vascular damage (milder BBB disruption, reduced inflammatory cell infiltration, decreased brain edema, and diminished hemorrhagic transformation). Mechanistic studies revealed less severe tight junction protein (TJP) loss and pericyte coverage reduction in α5-PKO mice after ischemia-reperfusion injury, indicating that the attenuated ischemic injury in α5-PKO mice is possibly due to less severe vascular damage. These findings suggest that mural cell-derived laminin-α5 plays a detrimental role in ischemic stroke and that inhibiting its signaling may have a neuroprotective effect.
Similar content being viewed by others
Introduction
The blood-brain barrier (BBB) is a dynamic structure mainly composed of brain microvascular endothelial cells (BMECs), pericytes, astrocytes, and a non-cellular component---the basement membrane (BM) [7, 57, 77]. By tightly regulating substance exchange between the CNS and circulation system, the BBB functions to maintain CNS homeostasis. Accumulating evidence suggests that BBB disruption contributes to the pathogenesis and progression of various neurological disorders [48, 81, 82]. For example, BBB breakdown affects inflammatory cell infiltration and is associated with the development/progression of ischemia-reperfusion injury [15, 32, 75]. It should be noted that the majority of BBB studies focus on its cellular constituents, and the role of the BM in BBB regulation remains largely unknown.
The BM consists of highly organized extracellular matrix proteins synthesized by astrocytes, BMECs, and mural cells, which include both pericytes and vascular smooth muscle cells (vSMCs) [29, 51, 67, 76]. Laminin, the only protein that is absolutely required for BM formation, is a trimer composed of α, β, and γ subunits [20, 51, 76, 77]. Among all five genetic variants of the α subunits, laminin-α4 and -α5 are highly expressed in blood vessels throughout the body [29, 67, 76]. Unlike laminin-α4, which is ubiquitously distributed in the vasculature, laminin-α5 expression shows a patchy pattern at smaller vessels [73]. The major cell types that synthesize laminin-α5 in the vasculature are BMECs and mural cells [26, 29, 46, 62, 65, 67, 80]. Recent studies demonstrated that knockout of laminin-α5 in endothelial cells failed to affect BBB permeability under homeostatic conditions [25, 63]. In TNFα-induced inflammation, however, these mutants showed significantly enhanced neutrophil extravasation in cremaster muscle [63]. In collagenase-induced intracerebral hemorrhage (ICH) model, these mutants displayed exacerbated inflammatory cell infiltration [25]. In addition, in the experimental autoimmune encephalomyelitis (EAE) model, decreased T cell infiltration into the brain and reduced disease susceptibility & severity were observed in laminin-α4 null mice [73], which exhibited compensatory and ubiquitous expression of laminin-α5 along the vasculature [73]. These findings suggest that endothelial laminin-α5 plays an inhibitory role in inflammatory cell extravasation under pathological conditions, although it is dispensable for BBB maintenance under physiological conditions [25, 63]. Whether mural cell-derived laminin-α5 is involved in BBB regulation under physiological and pathological conditions, however, remains unknown. Given that mural cell-derived laminin-α5 is an important component of the BM at the BBB [51, 76], we hypothesize that mural cell-derived laminin-α5 may also contribute to BBB integrity. In this study, we investigated the functions of mural cell-derived laminin-α5 in BBB regulation under homeostatic conditions and in ischemic stroke.
Materials and methods
Mice
The experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Georgia and were in accordance with the National Institute of Health Guide for Care and Use of Laboratory Animals. The Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines for reporting experiments involving animals were strictly followed. Laminin-α5flox/flox mice were generated as described previously [50]. Pdgfrβ-Cre+ mice were a generous gift from Dr. Volkhard Lindner. These two transgenic lines were crossed to generate laminin-α5flox/flox: Pdgfrβ-Cre+ (α5-PKO) mice. Their wildtype littermates were used as controls. In this study, 194 mice (102 control and 92 α5-PKO) were used. All mice were housed in the animal facility at the University of Georgia with free access to water and food.
Middle cerebral artery occlusion (MCAO)
Eight-week-old control and α5-PKO mice were subjected to 45 min of focal cerebral ischemia produced by transient intraluminal occlusion of the middle cerebral artery using a filament as described previously [49, 68]. Briefly, mice were anesthetized with 2,2,2-tribromoethyl alcohol (250 mg/kg, i.p.). A midline neck incision was made and the common carotid artery (CCA), external carotid artery (ECA), and internal carotid artery (ICA) on the right side were carefully isolated. The ECA and CCA were ligated distal to the carotid bifurcation. The ICA was clipped temporarily. A 6–0 silicone monofilament suture (Doccol) with a 0.21 mm diameter was introduced into the CCA via an incision, advanced 9 mm distal to the carotid bifurcation and secured in place. Successful occlusion of the middle cerebral artery was confirmed with the PeriCam PSI HR system (Perimed) based on laser speckle contrast analysis technology. Animals showing diminished blood flow of at least 80% during occlusion with at least 75% recovery of blood flow after reperfusion were used for experimentation. The body temperature was maintained at 37.0 ± 0.5 °C during the surgery using a heating pad. Animals had free access to food and water throughout the reperfusion period. This ischemic model led to ~ 30% and ~ 20% mortality rates for control and α5-PKO mice, respectively.
Body weight loss and neurological function
The body weight loss was evaluated daily from days 1 to 7 after surgery. Neurological function was assessed using the modified neurological severity scores (mNSS) system, which evaluates motor, sensory, reflex and balance functions, as described previously [16, 38, 58]. Briefly, mice were scored based on their performances in a variety of tests as described in Additional file 1: Table S1. The sum of these scores (0–14) was used to reflect their neurological function after MCAO. Higher scores indicate worse neurological function. Animals were habituated to the testing environment prior to experiments and the investigator who scored the animals was blinded to the genotypes.
Brain sectioning
Serial sectioning was used in this study. Briefly, 20 μm-thick serial sections were cut with Cryostat (Micro HM 550, Thermo Scientific). Eight sections evenly distributed along the rostral-to-caudal axis were collected from each brain.
Infarct volume and neuronal death
Brain infarct volume was quantified as infarct volume percentage (%) as described previously [43, 53, 56]. Briefly, cresyl violet-stained brain sections were imaged using the Nikon Eclipse Ti microscope. The areas of the contralateral hemisphere (Ci), ipsilateral hemisphere (Ii), and ipsilateral non-ischemic region (Ni) were determined using the Image J software (NIH), and the infarct volume (%) was calculated as:\( \mathrm{Infarctvolume}\left(\%\right)=\left(\frac{\sum \limits_i\left(\left(\frac{I_i-{N}_i}{I_i}\right){C}_i\right)}{2{\sum}_i{C}_i}\right)x100 \).
Neuronal death was assessed using Fluoro-Jade C (FJC) staining as described previously [59, 79]. Specifically, the number of FJC+ cells was counted in each field. At least 3 random fields from each section, 8 serial sections per brain, and 4 animals were used for quantification.
BBB permeability
Evans blue (EB) and/or FITC-Dextran (4kD) were used to assess BBB permeability as described previously [15]. Briefly, control and α5-PKO mice were injected retro-orbitally with 80 μl EB (2%, Sigma E2129) and/or 50 μl FITC-Dextran (25 mg/ml, Sigma FD4). For non-ischemic study, FITC-Dextran was allowed to circulate for 12 h. After transcardial perfusion, the brains were collected, homogenized in formamide, and centrifuged at 20,000 rpm for 20 min. The fluorescence intensity of the supernatant was measured using a SpectraMax M2 plate reader (Molecular Devices) at 450/550 nm. Mice without FITC-Dextran injection were used to determine baseline reading, which was subtracted from raw reading to obtain FITC-Dextran leakage. Leakage in α5-PKO mice was normalized to that in controls. For ischemic study, both tracers were injected 4 h before mice were transcardially perfused at each time point after injury. Each brain hemisphere was homogenized in formamide and centrifuged at 20,000 rpm for 20 min. The absorbance and fluorescence intensity of the supernatant were measured using a SpectraMax M2 plate reader at 620 nm and 450/550 nm, respectively. EB or FITC-Dextran leakage was defined as the difference of absorbance or fluorescence intensity between contralateral and ipsilateral hemispheres. Leakage in α5-PKO mice was normalized to that in controls.
Brain edema
Brain edema was assessed using both brain water content [79] and brain swelling [52, 69] and -α5 [46, 64, 65]. In addition, laminin-α2 has also been found in vSMCs from large vessels [45], such as the aorta and carotid arteries. There is also evidence showing that laminin-β1 is expressed in vSMCs in develo** vessels, whereas laminin-β2 is found in mature vasculature [28], suggesting a switch from β1- to β2-containing laminins during vessel maturation. Collectively, these results suggest that mural cells mainly express laminin-411, − 511, and possibly − 211 during development; and laminin-421, − 521, and possibly − 221 in adulthood under homeostatic conditions.
In this study, we failed to detect any changes in BBB permeability and CBF between control and α5-PKO mice under physiological conditions, suggesting that mural cell-derived α5-containing laminins are dispensable for BBB maintenance and CBF regulation under homeostatic conditions. Unlike these α5-PKO mice, mutants with laminin-γ1 deficiency (all γ1-containing laminins) in mural cells showed BBB breakdown and hydrocephalus in C57Bl6-FVB mixed background [26], suggesting an important role of mural cell-derived γ1-containing laminins in BBB maintenance and hydrocephalus pathogenesis, although we cannot exclude the possibility that BBB disruption is secondary to hydrocephalus. Together, these findings suggest the existence of compensation between mural cell-derived α5-containing laminins and α4/α2-containing laminins. In addition, it is also possible that the lack of phenotype in α5-PKO mice under homeostatic conditions is due to compensation by laminin isoforms from endothelial cells and/or astrocytes, which are in close proximity of mural cells [67]. For example, mural cell-derived α5-containing laminins and endothelial cell-derived laminin-511 may be able to compensate for each other’s loss. In support of this possibility, mice with laminin-α5 deficiency in endothelial cells are grossly normal and fail to show any defects under homeostatic conditions [25, 63].
After ischemia-reperfusion injury, α5-PKO mice demonstrated alleviated BBB disruption at days 1, 2, and 7 after injury. Consistent with the reduced BBB leakage, TJP (ZO-1 and claudin-5) levels were less severely reduced in the mutants at days 1 and 2 after injury. By day 7 after injury, however, BBB leakage but not TJP expression showed a significant difference between genotypes. This finding suggests that TJPs are not responsible for the difference in BBB integrity between genotypes at this time point, highlighting a possible role of transcytosis in BBB integrity maintenance. Echoed with this observation, tight junction-independent BBB disruption and the important role of transcytosis in BBB regulation have been reported in recent studies [2, 10, 17, 36, 71].
In addition, α5-PKO mice also displayed diminished inflammatory cell (neutrophil, lymphocyte, and mononuclear cell) infiltration, suggesting a “pro-infiltration” role of mural cell-derived laminin-α5 after ischemic injury. This is in contrast with a previously reported “anti-infiltration” role of endothelial laminin-α5. It has been demonstrated that loss of laminin-α5 in endothelial cells increased immune cell extravasation in cremaster muscle after inflammation [63] and in the brain after ICH [25]. In addition, in the EAE model, reduced infiltration of T lymphocytes in the brain was found in laminin-α4 null mice, which demonstrated compensatory & ubiquitous expression of laminin-α5 in the vasculature [73]. One explanation for this discrepancy is that mural cells and endothelial cells make different α5-containing laminins, which exert distinct functions to regulate immune cell extravasation. It should be noted, however, that we cannot exclude the possibility that mural cells make “new” laminin isoforms after ischemic injury, which are responsible for the observed “pro-infiltration” effect. Another possibility is that different injury/animal models and time points are responsible for this discrepancy. The “anti-infiltration” role of endothelial laminin-α5 is mainly supported by studies using a muscle inflammation model [63], an ICH model [25], and an EAE model [73], whereas the “pro-infiltration” role of mural cell-derived laminin-α5 is obtained from ischemia-reperfusion study. Unlike ischemia-reperfusion injury, the muscle inflammation model does not damage the BBB or the CNS. Additionally, loss of endothelial laminin-α5-induced increase of immune cell infiltration only occurs at a specific time point (1.5 h after TNFα injection) in this muscle inflammation model [63]. Although BBB disruption is replicated in the ICH model, brain pathology in ICH is completely different from that in ischemia-reperfusion injury. For example, blood vessel wall and BM are disrupted in the collagenase-induced ICH model, which causes immediate leakage of inflammatory cells into the brain, whereas such vascular damage is absent in the ischemia-reperfusion model. Therefore, it is unclear whether the increased accumulation of inflammatory cells in mutant brains is due to a direct “anti-infiltration” effect of endothelium-derived laminin-α5. In the EAE model, laminin-α4 global knockouts that showed compensatory up-regulation of laminin-α5 rather than endothelium-specific laminin-α5 knockouts were used [73]. Since mural cells also synthesize α4-containing laminins [30, 52, 69], both endothelium- and mural cell-derived laminin-α4 is ablated in these laminin-α4 knockouts. It is thus unclear whether the enhanced laminin-α5 is from endothelial cells or mural cells, which makes data interpretation difficult. We are currently investigating the role of endothelium-derived laminin-α5 in ischemic stroke using endothelium-specific laminin-α5 conditional knockout mice. Results from this study will contribute to our understanding of the biological function of endothelial laminin-α5.
α5-PKO mice exhibited milder vascular damage, such as less severe BBB disruption and decreased inflammatory cell infiltration, and attenuated neurological injury, including reduced ischemic volume, diminished neuronal death, and improved neurological function. Given that inflammatory cells actively contribute to secondary brain injury after stroke [1], we speculate that the attenuated neurological injury is due to milder vascular damage. In support of this possibility, extravasated neutrophils have been demonstrated to contribute to neuronal injury and brain edema in ischemic injury [12, 34, 37, 55, 60]. Similarly, lymphocytes are found to be responsible for delayed post-ischemic injury [39, 40]. In addition, monocytes have been shown to play a detrimental role in the acute phase (up to 3 days) after ischemic injury, although a beneficial role is reported in the chronic phase (after day 3) [21, 22]. Consistent with these reports, reduced numbers of neutrophils, lymphocytes, and mononuclear cells were observed in α5-PKO mice after ischemic injury, especially at early time points. It should be noted, however, that we are unable to exclude the possibility that attenuated neurological injury leads to milder vascular damage.
α5-PKO mice demonstrate a better outcome after ischemia-reperfusion injury, suggest a detrimental role of mural cell-derived laminin-α5 in ischemic injury. Similar to our α5-PKO mutants, mice with endothelium-specific deletion of integrin-α5 demonstrated substantially reduced infarct size, increased BBB integrity and improved neurological function after stroke [54], highlighting an adverse effect of endothelial integrin-α5 in ischemic stroke. Together, these findings suggest that mural cell-derived α5-containing laminins and endothelial integrin-α5 may use a converging signaling pathway to modulate the development/progression of ischemic stroke, although integrin-α5 is not a classical laminin receptor [6, 74]. Identifying the receptors and downstream signaling pathways may provide innovative molecular targets with therapeutic potential in ischemic stroke.
Due to the multiphasic nature of ischemic stroke, this study has a few limitations. First, only the transient ischemic model was used in this study. The transient ischemic model involves both ischemia and reperfusion. However, most strokes found in human patients only involve ischemia without reperfusion [19, 23, 42, 61, 70]. Thus, it is important to test the biological function of mural cell-derived laminin-α5 in the permanent ischemic model. Second, only one ischemic duration (45 min) was used in this study. It is known that longer occlusion causes more severe injury [44, 49]. Currently, various ischemic durations ranging from 30 to 120 min have been used in rodent MCAO studies [13, 14, 35, 49]. We chose 45-min ischemia for two reasons: (1) compared to other durations, 45-min ischemia consistently induced significant ischemic injury with less mortality in our hands, and (2) significant differences in stroke outcomes between control and α5-PKO mice were observed with 45-min ischemia. Other ischemic durations should be tested in future studies. Third, only young mice were used in this study. Aging is a risk factor for ischemic stroke and actively influences stroke outcomes [19, 23, 42]. Therefore, it is important to examine the biological function of mural cell-derived laminin-α5 in ischemic stroke using aged mice in the future. Fourth, unlike previous studies reporting improved outcomes in young female mice [19, 23, 42], we failed to observe gender differences in infarct volume, neurological severity score, and body weight loss. It should be noted that, although not statistically significant, a trend toward attenuated injury was observed in female mice independent of genotype. This discrepancy may be explained by the relatively small animal number used in each group and/or other factors, such as the severity of injury and sensitivity of assays. Future research is needed to address these limitations.
Conclusions
Collectively, our results suggest that mural cell-derived laminin-α5 is dispensable for BBB maintenance and CBF regulation under homeostatic condition. In ischemic stroke, however, loss of mural cell-derived laminin-α5 attenuates vascular damage and improves stroke outcomes, indicating a detrimental role of mural cell-derived laminin-α5 in ischemic stroke. These findings identify mural cell-derived laminin-α5 as a molecular target with therapeutic potential in ischemic stroke.
Abbreviations
- BBB:
-
Blood-brain barrier
- BM:
-
Basement membrane
- BMECs:
-
Brain microvascular endothelial cells
- CBF:
-
Cerebral blood flow
- CCA:
-
Common carotid artery
- CNS:
-
Central nervous system
- EAE:
-
Experimental autoimmune encephalomyelitis
- ECA:
-
External carotid artery
- ICA:
-
Internal carotid artery
- ICH:
-
Intracerebral hemorrhage
- MCAO:
-
Middle cerebral artery occlusion
- SMA:
-
Smooth muscle actin-α
- TEM:
-
Transmission electron microscopy
- TJP:
-
Tight junction protein
- vSMCs:
-
Vascular smooth muscle cells
References
Ahmad M, Graham SH (2010) Inflammation after stroke: mechanisms and therapeutic approaches. Transl Stroke Res 1:74–84. https://doi.org/10.1007/s12975-010-0023-7
Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C (2017) Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of Caveolae-mediated transcytosis. Neuron 94:581–594. https://doi.org/10.1016/j.neuron.2017.03.043
Andreone BJ, Lacoste B, Gu C (2015) Neuronal and vascular interactions. Annu Rev Neurosci 38:25–46. https://doi.org/10.1146/annurev-neuro-071714-033835
Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215. https://doi.org/10.1016/j.devcel.2011.07.001
Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557–561. https://doi.org/10.1038/nature09522
Aumailley M (2013) The laminin family. Cell Adhes Migr 7:48–55. https://doi.org/10.4161/cam.22826
Baeten KM, Akassoglou K (2011) Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 71:1018–1039. https://doi.org/10.1002/dneu.20954
Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain andduring brain aging. Neuron 68:409–427. https://doi.org/10.1016/j.neuron.2010.09.043
Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485:512–516. https://doi.org/10.1038/nature11087nature11087
Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C (2014) Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 509:507–511. https://doi.org/10.1038/nature13324
Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW (2007) Fluoro-jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice. Brain Res 1150:55–61. https://doi.org/10.1016/j.brainres.2007.02.078
Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N et al (2008) Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39:355–360. https://doi.org/10.1161/STROKEAHA.107.490128
Cai M, Zhang W, Weng Z, Stetler RA, Jiang X, Shi Y, Gao Y, Chen J (2017) Promoting neurovascular recovery in aged mice after ischemic stroke-prophylactic effect of Omega-3 polyunsaturated fatty acids. Aging Dis 8:531–545. https://doi.org/10.14336/AD.2017.0520
Carmichael ST (2005) Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2:396–409. https://doi.org/10.1602/neurorx.2.3.396
Chen B, Friedman B, Cheng Q, Tsai P, Schim E, Kleinfeld D, Lyden PD (2009) Severe blood-brain barrier disruption and surrounding tissue injury. Stroke 40:e666–e674. https://doi.org/10.1161/STROKEAHA.109.551341
Chen J, Zhang C, Jiang H, Li Y, Zhang L, Robin A, Katakowski M, Lu M, Chopp M (2005) Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 25:281–290. https://doi.org/10.1038/sj.jcbfm.9600034
Chow BW, Gu C (2015) The molecular constituents of the blood-brain barrier. Trends Neurosci 38:598–608. https://doi.org/10.1016/j.tins.2015.08.003
Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562–566. https://doi.org/10.1038/nature09513
Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26:1465–1478. https://doi.org/10.1038/sj.jcbfm.9600298
Durbeej M (2010) Laminins. Cell Tissue Res 339:259–268. https://doi.org/10.1007/s00441-009-0838-2
ElAli A, Jean LeBlanc N (2016) The role of monocytes in ischemic stroke pathobiology: new avenues to explore. Front Aging Neurosci 8:29. https://doi.org/10.3389/fnagi.2016.00029
Fang W, Zhai X, Han D, **ong X, Wang T, Zeng X, He S, Liu R, Miyata M, Xu B et al (2018) CCR2-dependent monocytes/macrophages exacerbate acute brain injury but promote functional recovery after ischemic stroke in mice. Theranostics 8:3530–3543. https://doi.org/10.7150/thno.24475
Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, Group S (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40:2244–2250. https://doi.org/10.1161/STROKEAHA.108.541128
Gambardella L, Zudaire E, Vermeren S (2012) Quantitative analysis of angiogenesis in the allantois explant model. The textbook of angiogenesis and Lymphangiogenesis: methods and applications. Springer, Dordrecht, pp 189–204
Gautam J, Miner JH, Yao Y (2019) Loss of endothelial laminin alpha5 exacerbates hemorrhagic brain injury. Transl Stroke Res. https://doi.org/10.1007/s12975-019-0688-5
Gautam J, Zhang X, Yao Y (2016) The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep 6(36450). https://doi.org/10.1038/srep36450
Gesuete R, Stevens SL, Stenzel-Poore MP (2016) Role of circulating immune cells in stroke and preconditioning-induced protection. Acta Neurochir Suppl 121:39–44. https://doi.org/10.1007/978-3-319-18497-5_7
Glukhova M, Koteliansky V, Fondacci C, Marotte F, Rappaport L (1993) Laminin variants and integrin laminin receptors in develo** and adult human smooth muscle. Dev Biol 157:437–447. https://doi.org/10.1006/dbio.1993.1147
Hannocks MJ, Pizzo ME, Huppert J, Deshpande T, Abbott NJ, Thorne RG, Sorokin L (2018) Molecular characterization of perivascular drainage pathways in the murine brain. J Cereb Blood Flow Metab 38:669–686. https://doi.org/10.1177/0271678X17749689
Iivanainen A, Kortesmaa J, Sahlberg C, Morita T, Bergmann U, Thesleff I, Tryggvason K (1997) Primary structure, developmental expression, and immunolocalization of the murine laminin alpha4 chain. J Biol Chem 272:27862–27868. https://doi.org/10.1074/jbc.272.44.27862
** R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779–789. https://doi.org/10.1189/jlb.1109766
** X, Liu J, Yang Y, Liu KJ, Yang Y, Liu W (2012) Spatiotemporal evolution of blood brain barrier damage and tissue infarction within the first 3h after ischemia onset. Neurobiol Dis 48:309–316. https://doi.org/10.1016/j.nbd.2012.07.007
Keep RF, Hua Y, ** G (2012) Brain water content: a misunderstood measurement? Transl Stroke Res 3:263–265. https://doi.org/10.1007/s12975-012-0152-2
Kim J, Song TJ, Park JH, Lee HS, Nam CM, Nam HS, Kim YD, Heo JH (2012) Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis 222:464–467. https://doi.org/10.1016/j.atherosclerosis.2012.02.042
Kraft P, Göb E, Schuhmann MK, Göbel K, Deppermann C, Thielmann I, Herrmann AM, Lorenz K, Brede M, Stoll G et al (2013) FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection. Stroke 44:3202–3210. https://doi.org/10.1161/STROKEAHA.113.002880
Krueger M, Hartig W, Reichenbach A, Bechmann I, Michalski D (2013) Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One 8:e56419. https://doi.org/10.1371/journal.pone.0056419
Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S (2013) Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis 22:e111–e117. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.08.008
Li Y, Chen J, Wang L, Lu M, Chopp M (2001) Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666–1672. https://doi.org/10.1212/WNL.56.12.1666
Liesz A, Hu X, Kleinschnitz C, Offner H (2015) Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke 46:1422–1430. https://doi.org/10.1161/STROKEAHA.114.008608
Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A et al (2011) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134:704–720. https://doi.org/10.1093/brain/awr008
Liu F, Schafer DP, McCullough LD (2009) TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods 179:1–8. https://doi.org/10.1016/j.jneumeth.2008.12.028
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K et al (2009) Good laboratory practice: preventing introduction of bias at the bench. Stroke 40:e50–e52. https://doi.org/10.1161/STROKEAHA.108.525386
McBride DW, Klebe D, Tang J, Zhang JH (2015) Correcting for brain swelling’s effects on infarct volume calculation after middle cerebral artery occlusion in rats. Transl Stroke Res 6:323–338. https://doi.org/10.1007/s12975-015-0400-3
McColl BW, Carswell HV, McCulloch J, Horsburgh K (2004) Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res 997:15–23. https://doi.org/10.1016/j.brainres.2003.10.028
McLean SE, Mecham BH, Kelleher CM, Mariani TJ, Mecham RP (2005) Extracellular matrix gene expression in the develo** mouse aorta. Adv Dev Biol 15:81–128. https://doi.org/10.1016/S1574-3349(05)15003-0
Miner JH, Lewis RM, Sanes JR (1995) Molecular cloning of a novel laminin chain, alpha 5, and widespread expression in adult mouse tissues. J Biol Chem 270:28523–28526. https://doi.org/10.1074/jbc.270.48.28523
Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR (1997) The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol 137:685–701. https://doi.org/10.1083/jcb.137.3.685
Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L et al (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85:296–302. https://doi.org/10.1016/j.neuron.2014.12.032
Morris GP, Wright AL, Tan RP, Gladbach A, Ittner LM, Vissel B (2016) A comparative study of variables influencing ischemic injury in the longa and Koizumi methods of intraluminal filament middle cerebral artery occlusion in mice. PLoS One 11:e0148503. https://doi.org/10.1371/journal.pone.0148503
Nguyen NM, Kelley DG, Schlueter JA, Meyer MJ, Senior RM, Miner JH (2005) Epithelial laminin alpha5 is necessary for distal epithelial cell maturation, VEGF production, and alveolization in the develo** murine lung. Dev Biol 282:111–125. https://doi.org/10.1016/j.ydbio.2005.02.031
Nirwane A, Yao Y (2019) Laminins and their receptors in the CNS. Biol Rev Camb Philos Soc 94:283–306. https://doi.org/10.1111/brv.12454
Petajaniemi N, Korhonen M, Kortesmaa J, Tryggvason K, Sekiguchi K, Fujiwara H, Sorokin L, Thornell LE, Wondimu Z, Assefa D et al (2002) Localization of laminin alpha4-chain in develo** and adult human tissues. J Histochem Cytochem 50:1113–1130. https://doi.org/10.1177/002215540205000813
Renolleau S, Aggoun-Zouaoui D, Ben-Ari Y, Charriaut-Marlangue C (1998) A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: morphological changes indicative of apoptosis. Stroke 29:1454–1460. https://doi.org/10.1161/01.STR.29.7.1454
Roberts J, de Hoog L, Bix GJ (2017) Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke. J Cereb Blood Flow Metab 37:85–96. https://doi.org/10.1177/0271678X15616979
Ross AM, Hurn P, Perrin N, Wood L, Carlini W, Potempa K (2007) Evidence of the peripheral inflammatory response in patients with transient ischemic attack. J Stroke Cerebrovasc Dis 16:203–207. https://doi.org/10.1016/j.jstrokecerebrovasdis.2007.05.002
Rousselet E, Kriz J, Seidah NG (2012) Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining. J Vis Exp:e4038. https://doi.org/10.3791/4038
Sá-Pereira I, Brites D, Brito MA (2012) Neurovascular unit: a focus on pericytes. Mol Neurobiol 45:327–347. https://doi.org/10.1007/s12035-012-8244-2
Schaar KL, Brenneman MM, Savitz SI (2010) Functional assessments in the rodent stroke model. Exp Transl Stroke Med 2:13. https://doi.org/10.1186/2040-7378-2-13
Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035:24–31. https://doi.org/10.1016/j.brainres.2004.11.054
Segel GB, Halterman MW, Lichtman MA (2011) The paradox of the neutrophilˈs role in tissue injury. J Leukoc Biol 89:359–372. https://doi.org/10.1189/jlb.0910538
Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR (2010) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8:e1000344. https://doi.org/10.1371/journal.pbio.1000344
Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM (2001) Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 153:933–946. https://doi.org/10.1083/jcb.153.5.933
Song J, Zhang X, Buscher K, Wang Y, Wang H, Di Russo J, Li L, Lütke-Enking S, Zarbock A, Stadtmann A et al (2017) Endothelial basement membrane laminin 511 contributes to endothelial junctional tightness and thereby inhibits leukocyte transmigration. Cell Rep 18:1256–1269. https://doi.org/10.1016/j.celrep.2016.12.092
Sorokin LM, Pausch F, Durbeej M, Ekblom P (1997) Differential expression of five laminin alpha (1-5) chains in develo** and adult mouse kidney. Dev Dyn 210:446–462. https://doi.org/10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G
Sorokin LM, Pausch F, Frieser M, Kroger S, Ohage E, Deutzmann R (1997) Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation. Dev Biol 189:285–300. https://doi.org/10.1006/dbio.1997.8668
Sussman ES, Connolly ES Jr (2013) Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol 4:69. https://doi.org/10.3389/fneur.2013.00069
Thomsen MS, Routhe LJ, Moos T (2017) The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab 37:3300–3317. https://doi.org/10.1177/0271678X17722436
Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O (2007) Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38:3032–3039. https://doi.org/10.1161/STROKEAHA.107.488445
Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y, Tryggvason K (2002) Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 22:1194–1202. https://doi.org/10.1128/MCB.22.4.1194-1202.2002
van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 7:e1000245. https://doi.org/10.1371/journal.pmed.1000245
Villasenor R, Lampe J, Schwaninger M, Collin L (2018) Intracellular transport and regulation of transcytosis across the blood-brain barrier. Cell Mol Life Sci. https://doi.org/10.1007/s00018-018-2982-x
Wang J, Tsirka SE (2005) Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36:613–618. https://doi.org/10.1161/01.STR.0000155729.12931.8f
Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E et al (2009) Endothelial basement membrane laminin α5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 15:519–527. https://doi.org/10.1038/nm.1957
Wu X, Reddy DS (2012) Integrins as receptor targets for neurological disorders. Pharmacol Ther 134:68–81. https://doi.org/10.1016/j.pharmthera.2011.12.008
Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42:3323–3328. https://doi.org/10.1161/STROKEAHA.110.608257
Yao Y (2017) Laminin: loss-of-function studies. Cell Mol Life Sci 74:1095–1115. https://doi.org/10.1007/s00018-016-2381-0
Yao Y (2019) Basement membrane and stroke. J Cereb Blood Flow Metab 39:3–19. https://doi.org/10.1177/0271678X18801467
Yao Y, Chen ZL, Norris EH, Strickland S (2014) Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 5(3413). https://doi.org/10.1038/ncomms4413
Yao Y, Tsirka SE (2012) The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage. Glia 60:908–918. https://doi.org/10.1002/glia.22323
Yousif LF, Di Russo J, Sorokin L (2013) Laminin isoforms in endothelial and perivascular basement membranes. Cell Adhes Migr 7:101–110. https://doi.org/10.4161/cam.22680
Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163:1064–1078. https://doi.org/10.1016/j.cell.2015.10.067
Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201. https://doi.org/10.1016/j.neuron.2008.01.003
Zudaire E, Gambardella L, Kurcz C, Vermeren S (2011) A computational tool for quantitative analysis of vascular networks. PLoS One 6:e27385. https://doi.org/10.1371/journal.pone.0027385
Acknowledgments
We thank Dr. Volkhard Lindner for the Pdgfrβ-Cre mice.
Funding
This study was supported, in part, by the American Heart Association grant 16SDG29320001 (to YY) and NIH R01DK078314 (to JHM).
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its supplementary information files.
Author information
Authors and Affiliations
Contributions
YY conceived & designed the experiments, performed data analyses, and wrote the manuscript; AN performed the experiments, collected & analyzed the data, wrote the manuscript; JJ and BN contributed to data analyses; JHM generated the laminin-α5 floxed mice & laminin-α5 antibody and contributed to data analyses. All authors have read and approved the final submission.
Corresponding author
Ethics declarations
Ethics approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file
Additional file 1:
Table S1. Modified Neurologic Severity Scores (mNSS) system. Figure S1. Angioarchitecture is unaltered in α5-PKO mice under homeostatic conditions. Figure S2. Spatial distribution of infarct area in control and α5-PKO mice at day 1 after ischemic injury. Figure S3. Comparison of gender-specific effects in control and α5-PKO mice after ischemic stroke. Figure S4. α5-PKO mice show reduced neuronal death in both penumbra and ischemic core after ischemic stroke. Figure S5. α5-PKO mice have reduced inflammatory cell infiltration after ischemic stroke. Figure S6. α5-PKO mice have reduced brain water content after ischemic stroke. (DOCX 2830 kb)
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Nirwane, A., Johnson, J., Nguyen, B. et al. Mural cell-derived laminin-α5 plays a detrimental role in ischemic stroke. acta neuropathol commun 7, 23 (2019). https://doi.org/10.1186/s40478-019-0676-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40478-019-0676-8